Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study

Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Flemming Skjøth, Karen Margrete Due, Torbjörn Callréus, Mary Rosenzweig, Gregory Y H Lip

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

389 Citationer (Scopus)

Abstract

The aim of this study was to assess the efficacy and safety in an "everyday clinical practice" population of anticoagulant-naïve patients with atrial fibrillation (AF) treated with dabigatran etexilate after its post-approval availability in Denmark, compared with warfarin.
OriginalsprogEngelsk
TidsskriftJournal of the American College of Cardiology
Vol/bind61
Udgave nummer22
Sider (fra-til)2264-2273
Antal sider10
ISSN0735-1097
DOI
StatusUdgivet - 4 jun. 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study'. Sammen danner de et unikt fingeraftryk.

Citationsformater